These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7797749)

  • 21. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor Vehicle Driving-Related Anxiety in Patients Undergoing Cardioverter Defibrillator Implantation and Cardiac Resynchronization Therapy With Defibrillators.
    Moriguchi S; Hitosugi M; Takeuchi Y; Inoue T; Takeda S; Baba M; Takeda A; Nakamura M; Inuzuka Y
    Ann Noninvasive Electrocardiol; 2024 Sep; 29(5):e70017. PubMed ID: 39323018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Automobile driving and implantable defibrillators].
    Lerecouvreux M; Aït Saïd M; Paziaud O; Perrier E; Carlioz R; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):288-93. PubMed ID: 15881843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions.
    Larsen GC; Stupey MR; Walance CG; Griffith KK; Cutler JE; Kron J; McAnulty JH
    JAMA; 1994 May; 271(17):1335-9. PubMed ID: 8158818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fitness to drive in patients with implanted cardioverter-defibrillator].
    Klein HH
    Dtsch Med Wochenschr; 2012 Sep; 137(39):1927-30. PubMed ID: 22996581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automatic implantable cardioverter defibrillator rhythm strip data as used in interpretation of a motor vehicle accident.
    Dolinak D; Guileyardo J
    Am J Forensic Med Pathol; 2001 Sep; 22(3):256-60. PubMed ID: 11563735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator.
    Anderson MH; Camm AJ
    Am Heart J; 1994 Apr; 127(4 Pt 2):1185-93. PubMed ID: 8160599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of teens-with-teens fatal crashes in the United States, 2005-2010.
    Williams AF; Tefft BC
    J Safety Res; 2014 Feb; 48():37-42. PubMed ID: 24529089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.
    Meissner MD; Lehmann MH; Steinman RT; Mosteller RD; Akhtar M; Calkins H; Cannom DS; Epstein AE; Fogoros RN; Liem LB
    J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society.
    Epstein AE; Baessler CA; Curtis AB; Estes NA; Gersh BJ; Grubb B; Mitchell LB; ;
    Circulation; 2007 Mar; 115(9):1170-6. PubMed ID: 17287391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in teenage crash risk during the last decade.
    Ferguson SA; Teoh ER; McCartt AT
    J Safety Res; 2007; 38(2):137-45. PubMed ID: 17478184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Driving and arrhythmia: a review of scientific basis for international guidelines.
    Banning AS; Ng GA
    Eur Heart J; 2013 Jan; 34(3):236-44. PubMed ID: 23086661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an education and follow-up programme for implantable cardioverter defibrillator-implanted patients.
    Cinar FI; Tosun N; Kose S
    J Clin Nurs; 2013 Sep; 22(17-18):2474-86. PubMed ID: 23551749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Driving restrictions advised by midwestern cardiologists implanting cardioverter defibrillators: present practices, criteria utilized, and compatibility with existing state laws.
    DiCarlo LA; Winston SA; Honoway S; Reed P
    Pacing Clin Electrophysiol; 1992 Aug; 15(8):1131-6. PubMed ID: 1381080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.